Sequence Name |
Description |
Length |
Blast Hits |
min E-value |
Similarity |
GO hits |
GO names |
Enzyme Codes |
InterPro Scan |
contig06301 |
---NA--- |
261 |
0 |
|
|
0 |
|
|
|
contig06302 |
---NA--- |
477 |
0 |
|
|
0 |
|
|
|
contig06303 |
---NA--- |
202 |
0 |
|
|
0 |
|
|
|
contig06304 |
---NA--- |
393 |
0 |
|
|
0 |
|
|
|
contig06305 |
---NA--- |
294 |
0 |
|
|
0 |
|
|
|
contig06306 |
likely ortholog of sapiens chromosome 9 open reading frame 5 |
246 |
20 |
1.15E-18 |
67.10% |
1 |
C:membrane |
|
|
contig06307 |
---NA--- |
254 |
0 |
|
|
0 |
|
|
|
contig06308 |
---NA--- |
262 |
0 |
|
|
0 |
|
|
|
contig06309 |
programmed cell death 4 |
250 |
20 |
4.05E-24 |
81.55% |
5 |
P:apoptosis; F:RNA binding; C:cytoplasm; P:negative regulation of cell cycle; C:nucleus |
|
|
contig06310 |
---NA--- |
250 |
0 |
|
|
0 |
|
|
|
contig06311 |
creatine testis isozyme |
245 |
20 |
3.12E-32 |
96.55% |
6 |
F:creatine kinase activity; F:protein binding; P:cellular chloride ion homeostasis; F:ATP binding; P:brain development; C:mitochondrion |
EC:2.7.3.2 |
|
contig06312 |
---NA--- |
692 |
0 |
|
|
0 |
|
|
|
contig06313 |
---NA--- |
313 |
0 |
|
|
0 |
|
|
|
contig06314 |
neural precursor cell developmentally down-regulated 1 |
408 |
20 |
1.70E-54 |
76.90% |
2 |
F:F; P:P |
|
|
contig06315 |
---NA--- |
287 |
0 |
|
|
0 |
|
|
|
contig06316 |
---NA--- |
336 |
0 |
|
|
0 |
|
|
|
contig06317 |
---NA--- |
397 |
0 |
|
|
0 |
|
|
|
contig06318 |
flavoprotein oxidoreductase |
241 |
20 |
4.53E-23 |
81.30% |
5 |
C:cytoskeleton; C:cytoplasm; F:monooxygenase activity; F:zinc ion binding; P:cellular aromatic compound metabolic process |
|
|
contig06319 |
novel protein vertebrate actin binding protein (scraps drosophila) |
261 |
20 |
1.74E-22 |
73.05% |
2 |
P:cell cycle; C:intracellular organelle |
|
|
contig06320 |
novel protein |
417 |
20 |
2.28E-46 |
84.50% |
4 |
P:glycerol metabolic process; P:carbohydrate metabolic process; F:glycerophosphodiester phosphodiesterase activity; F:carbohydrate binding |
EC:3.1.4.46 |
|
contig06321 |
---NA--- |
269 |
0 |
|
|
0 |
|
|
|
contig06322 |
---NA--- |
335 |
0 |
|
|
0 |
|
|
|
contig06323 |
---NA--- |
267 |
0 |
|
|
0 |
|
|
|
contig06324 |
---NA--- |
252 |
0 |
|
|
0 |
|
|
|
contig06325 |
---NA--- |
260 |
0 |
|
|
0 |
|
|
|
contig06326 |
dep domain containing 7 |
351 |
20 |
1.38E-11 |
74.70% |
4 |
; F:F; P:P; C:C |
|
|
contig06327 |
poly (adp-ribose) polymerase member 12 |
254 |
20 |
1.11E-16 |
56.20% |
6 |
F:metal ion binding; F:nucleic acid binding; F:NAD+ ADP-ribosyltransferase activity; F:transferase activity; F:zinc ion binding; C:nucleus |
|
|
contig06328 |
---NA--- |
257 |
0 |
|
|
0 |
|
|
|
contig06329 |
brefeldin a-inhibited guanine nucleotide-exchange protein 1 |
281 |
20 |
9.03E-32 |
62.80% |
7 |
F:myosin binding; F:F; F:binding; P:regulation of ARF protein signal transduction; F:ARF guanyl-nucleotide exchange factor activity; C:C; C:intracellular |
|
|
contig06330 |
fer-1-like myoferlin ( elegans) |
244 |
20 |
8.81E-19 |
85.20% |
5 |
C:integral to membrane; P:blood circulation; C:nuclear membrane; C:plasma membrane; P:muscle contraction |
|
|
contig06331 |
thioredoxin domain containing 1 |
252 |
20 |
5.14E-14 |
89.05% |
16 |
C:integral to membrane; P:cell redox homeostasis; P:DNA replication; F:electron carrier activity; P:anti-apoptosis; C:membrane fraction; P:positive regulation of growth; F:arsenate reductase (thioredoxin) activity; P:ER to Golgi vesicle-mediated transport; P:signal transduction; F:thiol-disulfide exchange intermediate activity; P:positive regulation of transcription, DNA-dependent; P:cell proliferation; P:leukocyte activation; C:endoplasmic reticulum membrane; P:response to stress |
|
|
contig06332 |
sortilin-related vps10 domain containing receptor 2 |
240 |
20 |
3.24E-21 |
71.90% |
3 |
C:integral to membrane; F:receptor activity; F:sugar binding |
|
|
contig06333 |
ribose 5-phosphate isomerase a |
258 |
20 |
8.34E-41 |
86.25% |
6 |
C:soluble fraction; P:pentose-phosphate shunt, non-oxidative branch; C:microsome; F:monosaccharide binding; P:ribose phosphate metabolic process; F:ribose-5-phosphate isomerase activity |
EC:5.3.1.6 |
|
contig06334 |
---NA--- |
242 |
0 |
|
|
0 |
|
|
|
contig06335 |
---NA--- |
248 |
0 |
|
|
0 |
|
|
|
contig06336 |
lambda 1 |
427 |
20 |
1.09E-24 |
73.35% |
1 |
F:oxidoreductase activity |
|
|
contig06337 |
---NA--- |
258 |
0 |
|
|
0 |
|
|
|
contig06338 |
phosphatidylinositol 4- beta |
242 |
20 |
4.21E-37 |
97.05% |
6 |
P:phosphoinositide phosphorylation; F:obs-phosphatidylinositol 4-kinase activity; P:phosphoinositide-mediated signaling; C:membrane; C:endoplasmic reticulum; C:mitochondrion |
EC:2.7.1.67 |
|
contig06339 |
programmed cell death 8 (apoptosis-inducing factor) |
630 |
20 |
2.84E-08 |
64.95% |
15 |
F:electron-transferring-flavoprotein dehydrogenase activity; P:DNA fragmentation involved in apoptosis; C:mitochondrion; F:FAD binding; F:DNA binding; C:mitochondrial outer membrane; P:apoptosis; P:apoptotic mitochondrial changes; C:cytoplasm; C:microsome; F:oxidoreductase activity; C:soluble fraction; C:mitochondrial intermembrane space; P:cell redox homeostasis; C:cytosol |
|
|
contig06340 |
---NA--- |
269 |
0 |
|
|
0 |
|
|
|
contig06341 |
akirin 2 |
356 |
20 |
2.41E-32 |
85.00% |
2 |
F:F; P:P |
|
|
contig06342 |
---NA--- |
300 |
0 |
|
|
0 |
|
|
|
contig06343 |
---NA--- |
276 |
0 |
|
|
0 |
|
|
|
contig06344 |
---NA--- |
273 |
0 |
|
|
0 |
|
|
|
contig06345 |
---NA--- |
291 |
0 |
|
|
0 |
|
|
|
contig06346 |
---NA--- |
446 |
0 |
|
|
0 |
|
|
|
contig06347 |
---NA--- |
241 |
0 |
|
|
0 |
|
|
|
contig06348 |
b-cell translocation gene anti-proliferative |
303 |
20 |
5.53E-21 |
66.55% |
12 |
P:cell migration; F:transcription cofactor activity; F:kinase binding; P:negative regulation of cell growth; P:regulation of apoptosis; P:positive regulation of angiogenesis; P:regulation of transcription; P:spermatid development; P:negative regulation of cell proliferation; P:positive regulation of endothelial cell differentiation; C:intracellular part; P:protein amino acid methylation |
|
|
contig06349 |
zinc finger protein 235 |
258 |
20 |
8.99E-19 |
56.50% |
3 |
F:nucleic acid binding; C:intracellular; P:transcription |
|
|
contig06350 |
---NA--- |
273 |
0 |
|
|
0 |
|
|
|
contig06351 |
---NA--- |
240 |
0 |
|
|
0 |
|
|
|
contig06352 |
---NA--- |
290 |
0 |
|
|
0 |
|
|
|
contig06353 |
crooked neck pre-mrna splicing factor-like 1 |
394 |
20 |
2.68E-63 |
62.30% |
3 |
P:RNA splicing; P:mRNA processing; C:nucleus |
|
|
contig06354 |
cytochrome ascorbate dependent 3 |
318 |
20 |
2.78E-28 |
78.45% |
8 |
C:lysosome; P:heme biosynthetic process; P:cellular iron ion homeostasis; C:endosome; F:oxidoreductase activity; C:membrane attack complex; P:iron ion transport; F:iron ion binding |
|
|
contig06355 |
---NA--- |
247 |
0 |
|
|
0 |
|
|
|
contig06356 |
leucine rich repeat containing 61 |
364 |
20 |
1.30E-54 |
78.10% |
3 |
P:P; F:protein binding; C:C |
|
|
contig06357 |
---NA--- |
351 |
0 |
|
|
0 |
|
|
|
contig06358 |
---NA--- |
276 |
0 |
|
|
0 |
|
|
|
contig06359 |
translation initiation factor if- mitochondrial precursor |
262 |
1 |
6.86E-19 |
73.00% |
0 |
|
|
|
contig06360 |
---NA--- |
331 |
0 |
|
|
0 |
|
|
|
contig06361 |
---NA--- |
243 |
0 |
|
|
0 |
|
|
|
contig06362 |
lin-52 homolog |
319 |
20 |
9.23E-40 |
97.95% |
1 |
P:multicellular organismal development |
|
|
contig06363 |
---NA--- |
237 |
0 |
|
|
0 |
|
|
|
contig06364 |
---NA--- |
266 |
0 |
|
|
0 |
|
|
|
contig06365 |
ubiquitin carboxyl-terminal esterase l3 |
250 |
20 |
3.67E-25 |
84.90% |
6 |
C:cytoplasm; P:protein deubiquitination; P:eating behavior; P:ubiquitin-dependent protein catabolic process; F:ubiquitin thiolesterase activity; P:adult walking behavior |
EC:3.1.2.15 |
|
contig06366 |
---NA--- |
296 |
0 |
|
|
0 |
|
|
|
contig06367 |
---NA--- |
189 |
0 |
|
|
0 |
|
|
|
contig06368 |
---NA--- |
282 |
0 |
|
|
0 |
|
|
|
contig06369 |
ubiquitin specific peptidase 7 |
259 |
20 |
2.79E-20 |
91.35% |
7 |
C:cytoplasm; P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process; F:ubiquitin thiolesterase activity; F:cysteine-type endopeptidase activity; F:protein C-terminus binding; C:nucleus |
EC:3.1.2.15; EC:3.4.22.0 |
|
contig06370 |
loc152217 protein |
291 |
8 |
2.60E-26 |
63.63% |
0 |
|
|
|
contig06371 |
---NA--- |
362 |
0 |
|
|
0 |
|
|
|
contig06372 |
---NA--- |
253 |
0 |
|
|
0 |
|
|
|
contig06373 |
---NA--- |
567 |
0 |
|
|
0 |
|
|
|
contig06374 |
---NA--- |
253 |
0 |
|
|
0 |
|
|
|
contig06375 |
---NA--- |
274 |
0 |
|
|
0 |
|
|
|
contig06376 |
---NA--- |
255 |
0 |
|
|
0 |
|
|
|
contig06377 |
member ras oncogene family |
261 |
20 |
2.67E-39 |
96.85% |
14 |
F:protein transporter activity; P:two-component signal transduction system (phosphorelay); P:small GTPase mediated signal transduction; P:regulation of transcription, DNA-dependent; F:DNA binding; F:ATP binding; P:ER to Golgi vesicle-mediated transport; F:GTPase activity; F:transcription factor binding; P:intracellular protein transport; C:Golgi apparatus; C:endoplasmic reticulum; F:GTP binding; C:plasma membrane |
EC:3.6.5.1; EC:3.6.5.2; EC:3.6.5.3; EC:3.6.5.4 |
|
contig06378 |
---NA--- |
270 |
0 |
|
|
0 |
|
|
|
contig06379 |
sv2 related protein |
242 |
20 |
1.19E-23 |
78.65% |
6 |
F:ion transmembrane transporter activity; C:cell junction; C:synaptic vesicle; P:ion transport; C:integral to membrane; C:synapse |
|
|
contig06380 |
---NA--- |
266 |
0 |
|
|
0 |
|
|
|
contig06381 |
---NA--- |
312 |
0 |
|
|
0 |
|
|
|
contig06382 |
ubiquitination factor ufd2 homolog ( cerevisiae) |
526 |
20 |
3.29E-92 |
92.10% |
9 |
C:cytoplasm; P:protein folding; P:apoptosis; F:ubiquitin-protein ligase activity; F:unfolded protein binding; F:enzyme binding; P:protein ubiquitination during ubiquitin-dependent protein catabolic process; P:response to UV; C:ubiquitin ligase complex |
EC:6.3.2.19 |
|
contig06383 |
---NA--- |
368 |
0 |
|
|
0 |
|
|
|
contig06384 |
---NA--- |
268 |
0 |
|
|
0 |
|
|
|
contig06385 |
---NA--- |
275 |
0 |
|
|
0 |
|
|
|
contig06386 |
---NA--- |
255 |
0 |
|
|
0 |
|
|
|
contig06387 |
---NA--- |
251 |
0 |
|
|
0 |
|
|
|
contig06388 |
---NA--- |
252 |
0 |
|
|
0 |
|
|
|
contig06389 |
ctr9 protein |
293 |
20 |
1.42E-40 |
98.15% |
4 |
P:somitogenesis; F:SH2 domain binding; P:pigmentation; P:neural crest cell development |
|
|
contig06390 |
---NA--- |
200 |
0 |
|
|
0 |
|
|
|
contig06391 |
---NA--- |
261 |
0 |
|
|
0 |
|
|
|
contig06392 |
pleckstrin homology domain family g (with ef domain) member 7 |
1903 |
20 |
0 |
68.55% |
2 |
P:regulation of Rho protein signal transduction; F:Rho guanyl-nucleotide exchange factor activity |
|
|
contig06393 |
---NA--- |
243 |
0 |
|
|
0 |
|
|
|
contig06394 |
---NA--- |
261 |
0 |
|
|
0 |
|
|
|
contig06395 |
---NA--- |
394 |
0 |
|
|
0 |
|
|
|
contig06396 |
---NA--- |
215 |
0 |
|
|
0 |
|
|
|
contig06397 |
---NA--- |
255 |
0 |
|
|
0 |
|
|
|
contig06398 |
formin homology 2 domain containing 1 |
283 |
20 |
6.87E-40 |
87.55% |
5 |
C:cytoskeleton; C:cytoplasm; F:actin binding; P:actin cytoskeleton organization; C:nucleus |
|
|
contig06399 |
ribosomal rna processing 1 homolog b |
247 |
8 |
2.32E-11 |
81.88% |
2 |
C:preribosome, small subunit precursor; P:rRNA processing |
|
|
contig06400 |
mitochondrial ribosomal protein l43 |
394 |
20 |
1.17E-26 |
84.00% |
1 |
C:mitochondrial large ribosomal subunit |
|
|
100 Rows returned.